Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats

Kidney International

Volumn 65, Issue 1, 2004, Pages 154-161

  Evan, Andrew P ^c   Bledsoe, Sharon B ^c   Smith, Susan B ^c   Bushinsky, David A ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b STRONG MEMORIAL HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; HYDROXYPROLINE; OSTEOPONTIN; THIAZIDE DIURETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MINERAL; CALCIUM ABSORPTION; CALCIUM OXALATE STONE; CELL PROLIFERATION; CONTROLLED STUDY; CRYSTALLIZATION; GENETIC ANALYSIS; HYPERCALCIURIA; IMMUNOHISTOCHEMISTRY; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID PHASE EXTRACTION; STONE FORMATION; X RAY DIFFRACTION;

EID: 0347362501     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00396.x     Document Type: Article

References (62)

1. MONK RD, BUSHINSKY DA: Kidney stones (chapter 28), in Williams Textbook of Endocrinology, 10th ed, edited by Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, Philadelphia, WB Saunders, 2003, pp 1411-1425
2. BUSHINSKY DA: Nephrolithiasis. J Am Soc Nephrol 9:917-924, 1998
3. ASPLIN JR, FAVUS MJ, COE FL: Nephrolithiasis, (chapter 40), in The Kidney, 6th ed, edited by Brenner BM, Philadelphia, WB Saunders Company, 2000, pp 1774-1819
4. COE FL, PARKS JH, ASPLIN JR: The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141-1152, 1992
5. BUSHINSKY DA: Renal lithiasis, in Kelly's Textbook of Medicine, edited by Humes HD. New York, Lippincott Williams & Wilkens, 2000, pp 1243-1248
6. MONK RD, BUSHINSKY DA: Nephrolithiasis and nephrocalcinosis, in Comprehensive Clinical Nephrology, edited by Johnson R, Frehally J, London, Mosby, 2000, pp 973-989
7. MONK RD, BUSHINSKY DA: Pathogenesis of idiopathic hypercalciuria, in Kidney Stones: Medical and Surgical Management, edited by Coe F, Favus M, Pak C, Parks J, Preminger G, Philadelphia, Lippincott-Raven, 1996, pp 759-772
8. LAERUM E, LARSEN S: Thiazide prophylaxis of urolithiasis: A double-blind study in general practice. Acta Med Scand 215:383-389, 1984
9. ETTINGER B, CITRON JT, LIVERMORE B, DOLMAN LI: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139:679-684, 1988
10. BUSHINSKY DA, BASHIR MA, RIORDON DR, et al: Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 55:602-612, 1999
11. BUSHINSKY DA, GRYNPAS MD, ASPLIN JR: Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int 59:1415-1423, 2001
12. BUSHINSKY DA, NEUMANN KJ, ASPLIN J, KRIEGER NS: Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55:234-243, 1999
13. BUSHINSKY DA, PARKER WR, ASPLIN JR: Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57:550-560, 2000
14. 3: A new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 101:2223-2232, 1998
15. ASPLIN JR, BUSHINSKY DA, SINGHARETNAM W, et al: Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51:640-645, 1997
16. TSURUOKA S, BUSHINSKY DA, SCHWARTZ GJ: Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51:1540-1547, 1997
17. 3 in bone from genetic hypercalciuric rats. Am J Physiol (Cell Physiol) 271:C130-C135, 1996
18. BUSHINSKY DA, GRYNPAS MD, NILSSON EL, et al: Stone formation in genetic hypercalciuric rats. Kidney Int 48:1705-1713, 1995
19. BUSHINSKY DA, KIM M, SESSLER NE, et al: Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45:58-65, 1994
20. KIM M, SESSLER NE, TEMBE V, et al: Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 43:189-196, 1993
21. LI X-Q, TEMBE V, HORWITZ GM, et al: Increased intestinal vitamin D receptor in genetic hypercalciuric rats: A cause of intestinal calcium hyperabsorption. J Clin Invest 91:661-667, 1993
22. BUSHINSKY DA, FAVUS MJ: Mechanism of hypercalciuria in genetic hypercalciuric rats: Inherited defect in intestinal calcium transport. J Clin Invest 82:1585-1591, 1988
23. BUSHINSKY DA, ASPLIN JR, GRYNPAS MD, et al: Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975-987, 2002
24. IIDA S, PECK AB, JOHNSON-TARDIEU J, et al: Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986-996, 1999
25. DE WATER R, NOORDERMEER C, VAN DER KWAST TH, et al: Calcium oxalate nephrolithiasis: Effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761-771, 1999
26. KHAN SR, THAMILSELVAN S: Nephrolithiasis: A consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 4:305-312, 2000
27. THAMILSELVAN S, KHAN SR: Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results in vivo and in vitro studies. J Nephrol 11:66-69, 1998
28. BUSHINSKY DA: Metabolic acidosis (chapter 136), in The Principles and Practice of Nephrology, edited by Jacobson HR, Striker GE, Klahr S, St. Louis, Mosby, 1995, pp 924-932
29. BRENT R, MCMARTIN K, PHILLIPS S, et al: Fomepizole for the treatment of ethylele glycol poisoning. N Engl J Med 340:832-838, 1999
30. BRENT J: Current management of ethylene glycol poisoning. Drugs 61:979-988, 2001
31. ISHIHARA K, SZERLIP HM: Anion gap acidosis. Semin Nephrol 18:83-97, 1998
32. ROBERTS JA, SEIBOLD HR: Ethylene glycol toxicity in the monkey. Toxicol Appl Pharmacol 15:624-631, 1969
33. BOVE KE: Ethylene glycol toxicity. Am J Clin Pathol 45:46-50, 1966
34. POLDELSKI V, JOHNSON A, WRIGHT S et al: Ethylene glycol-mediated tubular injury: Identification of critical metabolites and injury pathways. Am J Kidney Dis 38:339-348, 2001
35. HAGLER L, HERMAN RH: Oxalate metabolism. I. Am J Clin Nutr 26:758-765, 1973
36. 3, intestinal absorption, and renal mineral conservation in male rats. Am J Physiol 246 (Renal Fluid Electrolyte Physiol 15) 246:F140-F145, 1984
37. YASUE T: Histological identification of calcium oxalate. Acta Histochem Cytochem 2:83-95, 1969
38. STERNBERGER LA: Immunocytochemistry. 2nd ed, New York, J. Wiley, 1979
39. FISHER LW, TORCHIA DA, FOHR B, et al: Flexible structures of SIBLING proteins, bone sialoprotein and osteopontin. Biochem Biophysic Res Comm 280:460-465, 2001
40. WORCESTER EM, BESHENSKY AM: Osteopontin inhibits nucleation of calcium oxalate crystals. Ann NY Acad Sci 760:375-377, 1995
41. SHIRAGA H, MIN W, VANDUSEN WJ, et al: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430, 1992
42. JIANG XJ, FENG T, CHANG LS, et al: Expression of osteopontin mRNA in normal and stone-forming rat kidney. Urol Res 26:389-394, 1998
43. McKEE MD, NANCI A, KHAN SR: Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Min Res 10:1913-1929, 1995
44. YAGISAWA T, CHANDHOKE PS, FAN J, LUCIA S: Renal osteopontin expression in experimental urolithiasis. J Endourol 12:171-176, 1998
45. BOSKEY AL, MARESCA M, ULLRICH W, et al: Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Min 22:147-159, 1993
46. HUNTER GK, KYLE CL, GOLDBERG HA: Modulation of crystal formation by bone phosphoproteins: Structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 300:723-728, 1994
47. CHAU H, EL-MAADAWY S, MCKEE MD, TENENHOUSE HS: Renal calcification in mice homozygous for the disrupted type IIa Na/Pi co-transporter gene Npt2. J Bone Min Res 18:644-657, 2003
48. CARR RJ: A new theory on the formation of renal calculi. Br J Urol 26:105-117, 1953
49. LILIEN OM, HAMMOND WS, KRAUSS DJ, et al: The microgenesis of some renal calculi. J Urol 18:451-456, 1981
50. HAMMES MS, LIESKE JC, PAWAR S, et al: Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 48:501-509, 1995
51. SCHEID C, HONEYMAN T, KOHJIMOTO Y, et al: Oxalate-induced changes in renal epithelial cell function: Role in stone disease. Mol Urol 4:371-382, 2000
52. KOUL H, KENNINGTON L, HONEYMAN T, et al: Activation of c-myc gene mediates the mitogenic effects of oxalate in LLC-PK1 cells, a line of renal epithelial cells. Kidney Int 50:1525-1530, 1996
53. JONASSEN JA, COONEY R, KENNINGTON L, et al: Oxalate-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol (Suppl) 14:S446-S451, 1999
54. LIESKE JC, TOBACK FG: Renal cell-urinary crystal interactions. Curr Opin Nephrol Hypertens 9:349-355, 2000
55. LIESKE JC, SWIFT HS, MARTIN T, et al: Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci 91:6987-6991, 1994
56. LIESKE JC, NORRIS R, SWIFT H, TOBACK FG: Adhesion, internalization and metabolism of calcium oxalate monohydrate crystals by renal epithelial cells. Kidney Int 52:1291-1301, 1997
57. LIESKE JC, TOBACK FG, DEGANELLO S: Direct nucleation of calcium oxalate dihydrate crystals onto the surface of living renal epithelial cells in culture. Kidney Int 54:796-803, 1998
58. WIESSNER JH, HASEGAWA AT, HUNG LY, et al: Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 59:637-644, 2001
59. FINLAYSON B, REID F: The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442-448, 1978
60. EVAN AP, LINGEMAN JE, PARKS JH, et al: Randall plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607-616, 2003
61. BUSHINSKY DA: Nephrolithiasis: site of the initial solid phase. J Clin Invest 111:602-605, 2003
62. ASPLIN JR, PARKS JH, COE FL: Dependence of upper limit of metastablility on supersaturation in nephrolithiasis. Kidney Int 52:1602-1608, 1997